Skip to main content
Top
Published in: Techniques in Coloproctology 3/2014

01-03-2014 | Original Article

Results from an American Society of Colon and Rectal Surgeons survey on the management of young-onset colorectal cancer

Authors: S. K. Warrier, M. F. Kalady, R. P. Kiran, J. M. Church

Published in: Techniques in Coloproctology | Issue 3/2014

Login to get access

Abstract

Background

Young patients with colorectal cancer (CRC) present a diagnostic and clinical challenge. The aim of our study was to survey the approaches to preoperative evaluation and clinical management of young patients with CRC by colorectal surgeons in North America.

Methods

A standard electronic survey was sent to the members of the American Society of Colon and Rectal Surgeons. The survey polled management decisions in various clinical scenarios for CRC patients less than 50 years old. Survey responses were collated and analyzed.

Results

One hundred ninety surgeons responded and 140 completed the entire survey (response rate 10 %). Eighty percent of surgeons would offer preoperative genetic testing if the patient’s family met the Amsterdam criteria compared to only 67 % if the criteria were not met. Of those offering preoperative tumor testing, 48 % test microsatellite instability, 19 % mismatch repair protein expression by immunohistochemistry, and 24 % offer both. Decisions regarding the extent of the resection for cancer were dependent on family history: Most members (86 %) would perform a segmental colectomy for CRC in a patient without family history. Eighty-four percent of respondents would offer a total abdominal colectomy if preoperative tests indicated Lynch syndrome. When questioned about MYH-associated polyposis, only 27 % recognized the appropriate diagnosis.

Conclusions

Among the American Society of Colon and Rectal Surgeons, family history influences preoperative testing and surgical management decisions. A significant portion of surgeons do not offer preoperative genetic testing, despite implications on operative management, postoperative surveillance, and screening of family members.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef
2.
go back to reference Edwards BK, Ward E, Kohler BA et al (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, an treatment) to reduce future rates. Cancer 116:544–573PubMedCentralPubMedCrossRef Edwards BK, Ward E, Kohler BA et al (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, an treatment) to reduce future rates. Cancer 116:544–573PubMedCentralPubMedCrossRef
3.
go back to reference You NY, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young onset colorectal cancer: is it time to pay attention? Arch Intern Med 13:287–289CrossRef You NY, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young onset colorectal cancer: is it time to pay attention? Arch Intern Med 13:287–289CrossRef
4.
go back to reference Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 21:1481–1487CrossRef Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 21:1481–1487CrossRef
5.
go back to reference Southey MC, Jenkins MA, Mead L et al (2005) Use of molecular tumour characteristics to prioritise mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23:6524–6532PubMedCrossRef Southey MC, Jenkins MA, Mead L et al (2005) Use of molecular tumour characteristics to prioritise mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23:6524–6532PubMedCrossRef
6.
go back to reference Lynch HT, Riley BD, Weismann S et al (2004) Hereditary non-polyposis colorectal carcinoma (HNPCC) and HNPCC-like families; problems in diagnosis, surveillance and management. Cancer 100:53–64PubMedCrossRef Lynch HT, Riley BD, Weismann S et al (2004) Hereditary non-polyposis colorectal carcinoma (HNPCC) and HNPCC-like families; problems in diagnosis, surveillance and management. Cancer 100:53–64PubMedCrossRef
7.
go back to reference Warrier SK, Trainer AH, Lynch AC et al (2011) Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54:1480–1487PubMedCrossRef Warrier SK, Trainer AH, Lynch AC et al (2011) Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54:1480–1487PubMedCrossRef
9.
go back to reference Lindor N, Rabe K, Petersen G et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985PubMedCentralPubMedCrossRef Lindor N, Rabe K, Petersen G et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985PubMedCentralPubMedCrossRef
10.
go back to reference Polamaki GE, McCalin MR, Melilo S, Hampell H, Thibodeau SN (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42–65CrossRef Polamaki GE, McCalin MR, Melilo S, Hampell H, Thibodeau SN (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42–65CrossRef
11.
go back to reference Shia J (2008) Immunohistochemistry versus microsatellite testing for screening colorectal cancer at risk for hereditary nonpolyposis colorectal cancer syndrome. Part 1. The utility of immunohistochemistry. J Mol Diagn 10:293–300PubMedCentralPubMedCrossRef Shia J (2008) Immunohistochemistry versus microsatellite testing for screening colorectal cancer at risk for hereditary nonpolyposis colorectal cancer syndrome. Part 1. The utility of immunohistochemistry. J Mol Diagn 10:293–300PubMedCentralPubMedCrossRef
12.
go back to reference Kalady MF, McGannon E, Vogel JD et al (2010) Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 252:507–513PubMed Kalady MF, McGannon E, Vogel JD et al (2010) Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 252:507–513PubMed
13.
go back to reference Lindor NM (2009) Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders. Best Pract Res Clin Gastroenterol 23:75–87PubMedCrossRef Lindor NM (2009) Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders. Best Pract Res Clin Gastroenterol 23:75–87PubMedCrossRef
14.
go back to reference Kalady MF, Lipman J, McGannon E, Church JM (2012) Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255:1121–1125PubMedCrossRef Kalady MF, Lipman J, McGannon E, Church JM (2012) Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255:1121–1125PubMedCrossRef
15.
go back to reference Win AK, Parry S, Parry B et al (2013) Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 20:1829–1836PubMedCrossRef Win AK, Parry S, Parry B et al (2013) Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 20:1829–1836PubMedCrossRef
16.
go back to reference Delaney CP, Fazio VW, Remzi FH et al (2003) Prospective, age related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 238:221–228PubMedCentralPubMed Delaney CP, Fazio VW, Remzi FH et al (2003) Prospective, age related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 238:221–228PubMedCentralPubMed
17.
go back to reference Hendriks YM, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counselling and surveillance. Gastroenterology 127:17–25PubMedCrossRef Hendriks YM, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counselling and surveillance. Gastroenterology 127:17–25PubMedCrossRef
18.
go back to reference Ringland CL, Arkenau HT, O’Connell DL, Ward RL (2010) Second primary colorectal cancers (SPCRs): experiences from a large Australian cancer registry. Ann Oncol 21:92–97PubMedCrossRef Ringland CL, Arkenau HT, O’Connell DL, Ward RL (2010) Second primary colorectal cancers (SPCRs): experiences from a large Australian cancer registry. Ann Oncol 21:92–97PubMedCrossRef
19.
go back to reference Church J, Heald B, Burke C, Kalady M (2012) Understanding MYH- associated neoplasia. Dis Colon Rectum 55:359–362PubMedCrossRef Church J, Heald B, Burke C, Kalady M (2012) Understanding MYH- associated neoplasia. Dis Colon Rectum 55:359–362PubMedCrossRef
20.
go back to reference Church J, Simmang C (2003) Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 46:1001–1012PubMedCrossRef Church J, Simmang C (2003) Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 46:1001–1012PubMedCrossRef
21.
go back to reference Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124:544–560PubMedCrossRef Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124:544–560PubMedCrossRef
22.
go back to reference Bellizzi AM, Frankel WL (2009) Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 16:405–417PubMedCrossRef Bellizzi AM, Frankel WL (2009) Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 16:405–417PubMedCrossRef
23.
go back to reference Vasen HF, Watson P, Khan PM (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425PubMedCrossRef Vasen HF, Watson P, Khan PM (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425PubMedCrossRef
24.
go back to reference Parry S, Win AK, Parry B et al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60:950–957PubMedCrossRef Parry S, Win AK, Parry B et al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60:950–957PubMedCrossRef
25.
go back to reference Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynaecological cancers in the Lynch syndrome. N Engl J Med 354:261–269PubMedCrossRef Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynaecological cancers in the Lynch syndrome. N Engl J Med 354:261–269PubMedCrossRef
26.
go back to reference Nielson M, Morreau H, Vasen HF, Hes HF (2010) MUTYH- associated polyposis (MAP). Crit rev Oncol/Haematol 2010 Nielson M, Morreau H, Vasen HF, Hes HF (2010) MUTYH- associated polyposis (MAP). Crit rev Oncol/Haematol 2010
27.
go back to reference Warrier SK, Lynch AC, Heriot AG (2013) A binational perspective on the management of young patients with colorectal cancer. ANZ J Surg. doi:10.1111/ans.12071 Warrier SK, Lynch AC, Heriot AG (2013) A binational perspective on the management of young patients with colorectal cancer. ANZ J Surg. doi:10.​1111/​ans.​12071
Metadata
Title
Results from an American Society of Colon and Rectal Surgeons survey on the management of young-onset colorectal cancer
Authors
S. K. Warrier
M. F. Kalady
R. P. Kiran
J. M. Church
Publication date
01-03-2014
Publisher
Springer Milan
Published in
Techniques in Coloproctology / Issue 3/2014
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-013-1052-5

Other articles of this Issue 3/2014

Techniques in Coloproctology 3/2014 Go to the issue